Empfehlung
5,8
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
25.7
1 neu, 0 erhöht, 2,1M $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Emergent BioSolutions Inc. |
|---|---|
| Ticker | EBS |
| CIK | 0001367644 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | 29089q105 |
|---|---|
| ISIN | US29089Q1058 |
| Typ | Common Stock |
| Titel | EMERGENT BIOSOLUTIONS INC. CMN |
Status
| Zuletzt geprüft | 2026-03-20 22:37:14.560922 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 742,900,000 | 52,600,000 | 0.93 | 1,318,600,000 | 522,600,000 |
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Ancora Advisors LLC | 170,469 | 0 | 170,469 | 2,106,997 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | Richard Ronald | Director | Open Market Sale | -7,100 | 12.11 | -85,990.23 | -43,2% | |
| 2025-12-05 | Richard Ronald | Director | Open Market Sale | -14,884 | 11.90 | -177,086.86 | -89,0% | |
| 2025-11-10 | DeGolyer Donald W | Director | Open Market Sale | -17,801 | 10.54 | -187,622.54 | -94,3% | |
| 2025-11-07 | Dayal Sujata Tyagi | Director | Open Market Sale | -8,552 | 10.00 | -85,520.00 | -43,0% | |
| 2025-10-07 | Glessner Coleen | Officer, EVP, Quality & Ethics, and CPL | Open Market Sale | -30,608 | 10.00 | -306,080.00 | -153,8% | |
| 2025-05-23 | Katkin Keith | Director | Open Market Sale | -7,844 | 6.30 | -49,417.20 | -24,8% | |
| 2025-05-23 | Katkin Keith | Director | Open Market Sale | -7,844 | 6.30 | -49,417.20 | -24,8% | |
| 2025-05-13 | PAPA JOSEPH C | Director, Officer, President and CEO | Open Market Purchase | 60,000 | 5.83 | 349,800.00 | +175,7% | |
| 2025-05-13 | PAPA JOSEPH C | Director, Officer, President and CEO | Open Market Purchase | 60,000 | 5.83 | 349,800.00 | +175,7% | |
| 2025-05-13 | PAPA JOSEPH C | Director, Officer, President and CEO | Open Market Purchase | 60,000 | 5.83 | 349,800.00 | +175,7% |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Ancora Advisors LLC | 170,469 | 2,106,997 | 100.00 |